Supporting and promoting innovative, fast-to-patient drug discovery
The Medicines Discovery Catapult can help you develop the market and your technology in line with the UK Life Sciences Industrial Strategy.
The Medicines Discovery Catapult is a national centre of applied research and development expertise which promotes and supports innovative, fast-to-patient drug discovery in the UK through collaborative projects across the community.
The Catapult’s community includes contract research organisations (CROs), biotechs, medical charities, technology and pharma companies. With their¬†facilities and expertise, the Catapult enables the sector to solve common problems, de-risk IP and create new products and services.
They are hosting a webinar on¬†Tuesday 10th October 2017,¬†10:30 – 11:30 , to provide CROs with an opportunity to learn more about the Catapult. They are also keen to hear about your priorities and how you think the Catapult can best support your work. They¬†are inviting CROs from across areas of expertise to take part in the webinar, including companies specialising in:
- in vitro
- in silico and analytics
- discovery services
- early development services
You can register for the webinar here.
If you would like to discuss innovation opportunities for medicines discovery with KTN¬†please contact Dr Sarah Goulding (Specialist, Medicines and Advanced Therapies) or Alexander Henzing (Knowledge Transfer Manager, Bioinformatics).